Parametric Portfolio Associates’s Cymabay Therapeutics CBAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.04M	Buy	334,713 +95,698	+40%	+$301K	﹤0.01%	2766
2021 Q4	$808K	Buy	239,015 +2,258	+1%	+$8.57K	﹤0.01%	2867
2021 Q3	$864K	Buy	236,757 +21,817	+10%	+$86K	﹤0.01%	2865
2021 Q2	$937K	Sell	214,940 -88,939	-29%	-$394K	﹤0.01%	2799
2021 Q1	$1.38M	Sell	303,879 -240,146	-44%	-$1.29M	﹤0.01%	2997
2020 Q4	$3.12M	Sell	544,025 -7,233	-1%	-$54.8K	﹤0.01%	2384
2020 Q3	$3.99M	Sell	551,258 -25,460	-4%	-$136K	﹤0.01%	2050
2020 Q2	$2.01M	Buy	576,718 +404,078	+234%	+$1.17M	﹤0.01%	2501
2020 Q1	$256K	Buy	172,640 +57,663	+50%	+$96.8K	﹤0.01%	3446
2019 Q4	$225K	Sell	114,977 -66,543	-37%	-$250K	﹤0.01%	3698
2019 Q3	$929K	Buy	181,520 +151,682	+508%	+$918K	﹤0.01%	3063
2019 Q2	$214K	Buy	29,838 +4,920	+20%	+$55.7K	﹤0.01%	3721
2019 Q1	$331K	Buy	24,918 +9,316	+60%	+$99.1K	﹤0.01%	3515
2018 Q4	$123K	Buy	+15,602	New	+$149K	﹤0.01%	3759
2018 Q2	–	Sell	-122,984	Closed	-$1.6M	–	3953
2018 Q1	$1.6M	Sell	122,984 -14,099	-10%	-$175K	﹤0.01%	2759
2017 Q4	$1.26M	Sell	137,083 -7,822	-5%	-$66.8K	﹤0.01%	2893
2017 Q3	$1.17M	Buy	+144,905	New	+$980K	﹤0.01%	2944